Anthology - About the company
Anthology is a seed company based in Cambridge (United States), founded in 2023 by Jing Zhang, Charles Jo and Tzu-Chieh Tang. It operates as a Biomanufacturing company that generates diverse genomes to scale and digitalize the industry. Anthology has raised an undisclosed amount in funding from Climate Capital. The company has 844 active competitors, including 98 funded and 87 that have exited. Its top competitors include companies like Strand Life Sciences, Tessera Therapeutics and BGI.
Company Details
Biomanufacturing company that generates diverse genomes to scale and digitalize the industry. It aim to accelerate genetic mutation and selection processes to create new workhorses for bioproduction, overcoming challenges like expensive feedstocks and low yields.
Key Metrics
Founded Year
2023
Location
Cambridge, United States
Stage
Seed
Latest Funding Round
Investors
Ranked
93rd among 844 active competitors
Employee Count
21 as on May 31, 2026
Similar Companies
Sign up to download Anthology's company profile
Anthology's funding and investors
Anthology has raised funding over 1 round. Its latest funding round was a Seed round on 2023 for $*****. 1 investor participated in its latest round. Anthology has 4 institutional investors.
Here is the list of recent funding rounds of Anthology:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
2023 | 7173 | Seed | 8404 | 2853 | 8124 | 4682 |
Access funding benchmarks and valuations. Sign up today!View details of Anthology's funding rounds and investors
Anthology's founders and board of directors
Founder? Claim ProfileThe founders of Anthology are Jing Zhang, Charles Jo and Tzu-Chieh Tang. Jing Zhang is the CEO of Anthology.
Here are the details of Anthology's key team members:
- Jing Zhang: Co-Founder & CEO of Anthology. Contact Info: 1 email address
- Charles Jo: Co-Founder of Anthology.
- Tzu-Chieh Tang: Co-Founder of Anthology.
View details of Anthology's Founder profiles and Board Members
Anthology's employee count trend
Anthology has 21 employees as of May 26. Here is Anthology's employee count trend over the years:
Uncover Anthology's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Anthology's Competitors and alternates
Top competitors of Anthology include Strand Life Sciences, Tessera Therapeutics and BGI. Here is the list of Top 10 competitors of Anthology, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Strand Life Sciences 2000, Bengaluru (India), Acquired | Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | $34.9M | 73/100 | |
2nd | Tessera Therapeutics 2017, Cambridge (United States), Series C | Provider of new genome engineering technology for treating multiple diseases | $610M | 64/100 | |
3rd | Provider of services in genome sequencing | - | 64/100 | ||
4th | Hexagon Bio 2017, Menlo Park (United States), Series B | Provider of bioinformatics tools for the analysis of microbial genomic sequencing data | $206M | 63/100 | |
5th | AI-based oncology therapy plan solution for professionals | $43M | 60/100 | ||
6th | Singular Genomics 2016, San Diego (United States), Acquired | Provider of next-generation gene sequencing and multi-omics technologies | - | 60/100 | |
7th |  Omniome 2013, San Diego (United States), Acquired | Provider of genome sequencing platform | $160M | 59/100 | |
8th | Novogene Corporation 2011, Beijing (China), Series B | Provider of genomic services and solutions | $75M | 59/100 | |
9th | Replay 2021, San Diego (United States), Acquired | Provider of genomic reprogramming platform for writing and delivering big DNA | $55M | 58/100 | |
10th | Provider of bioinformatics tools for the analysis of genome sequencing data | $48.8M | 57/100 | ||
93rd |  Anthology 2023, Cambridge (United States), Seed | Biomanufacturing company that generates diverse genomes to scale and digitalize the industry | - | 38/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Anthology's competitors? Click here to see the top ones
Anthology's Investments and acquisitions
Anthology has made no investments or acquisitions yet.
Reports related to Anthology
Here is the latest report on Anthology's sector:
Are you a Founder ?
FAQs about Anthology
Explore our recently published companies
- Q Space Labs - Bengaluru based, 2025 founded, Unfunded company
- Folium Sensing - Chennai based, 2024 founded, Unfunded company
- PrecizionIQ - Faridabad based, 2022 founded, Unfunded company
- Instruo - Kochi based, 2024 founded, Funding Raised company
- Niram Tech Services - Vellore based, 2025 founded, Unfunded company
- Aristoverse - Chennai based, 2024 founded, Unfunded company
